Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsTURNBULL, Catriona M; CENA, Clara; FRUTTERO, Roberta et al.British journal of pharmacology. 2006, Vol 148, Num 4, pp 517-526, issn 0007-1188, 10 p.Article

Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused ratsYILONG FU; ZHONGJING WANG; WOEI LEE CHEN et al.American journal of physiology. Heart and circulatory physiology. 2007, Vol 62, Num 3, issn 0363-6135, H1545-H1552Article

Recent developments in nitric oxide donor drugsMILLER, M. R; MEGSON, I. L.British journal of pharmacology. 2007, Vol 151, Num 3, pp 305-321, issn 0007-1188, 17 p.Article

Evaluation of nitrate-substituted pseudocholine esters of aspirin as potential nitro-aspirinsGILMER, John F; MORIARTY, Louise M; CLANCY, John M et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 11, pp 3217-3220, issn 0960-894X, 4 p.Article

Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cellsNATH, Niharika; CHATTOPADHYAY, Mitali; KODELA, Ravinder et al.Biochemical pharmacology. 2010, Vol 79, Num 12, pp 1759-1771, issn 0006-2952, 13 p.Article

Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersGRESELE, Paolo; MOMI, Stefania.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 2, pp 148-168, issn 0897-5957, 21 p.Article

NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cellsSPIEGEL, Adam; HUNDLEY, Thomas R; JIE CHEN et al.Biochemical pharmacology. 2005, Vol 70, Num 7, pp 993-1000, issn 0006-2952, 8 p.Article